These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 718020)

  • 21. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
    Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).
    Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P
    Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
    Desombere I; Willems A; Gijbels Y; Leroux-Roels G
    J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine against hepatitis B in children: prevention of hepatitis in a pediatric hemodialysis unit.
    Nivet H; Drucker J; Dubois F; Goudeau A; Coursaget P; Rolland JC; Grenier B; Maupas P
    Int J Pediatr Nephrol; 1982 Mar; 3(1):25-8. PubMed ID: 7107116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression, purification, and characterization of hepatitis B virus surface antigens (HBsAg) in yeast Pichia Pastoris.
    Liu R; Lin Q; Sun Y; Lu X; Qiu Y; Li Y; Guo X
    Appl Biochem Biotechnol; 2009 Aug; 158(2):432-44. PubMed ID: 19184543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A program to provide hepatitis B immunoprophylaxis to infants born to HBsAg-positive Asian and Pacific Island women.
    Klontz KC
    West J Med; 1987 Feb; 146(2):195-9. PubMed ID: 3825119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
    Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae.
    Jung J; Iijima M; Yoshimoto N; Sasaki M; Niimi T; Tatematsu K; Jeong SY; Choi EK; Tanizawa K; Kuroda S
    Protein Expr Purif; 2011 Aug; 78(2):149-55. PubMed ID: 21515381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of pre-S gene products in HBsAg carriers and in hepatitis B vaccines].
    Gerken G; Manns M; Kyriatsoulis A; Hess G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1988 Jul; 26(7):374-9. PubMed ID: 2851893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression, purification and characterization of the Hepatitis B virus entire envelope large protein in Pichia pastoris.
    Han X; Ye LB; Li BZ; Bo G; Cai WJ; Hong Z; She YL; Li Y; Kong LB; Wu ZH
    Protein Expr Purif; 2006 Oct; 49(2):168-75. PubMed ID: 16829133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization.
    Goudeau A; Lo KJ; Coursaget P; Tong MJ; Yeh CL; Tsai YT; Lee JK; Wu TC; Yeh SH; Lee SD
    Dev Biol Stand; 1983; 54():399-404. PubMed ID: 6228473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The preparation and safety of hepatitis B vaccine.
    Hilleman MR; McAleer WJ; Buynak EB; McLean AA
    J Infect; 1983 Jul; 7 Suppl 1():3-8. PubMed ID: 6674367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunochemical structure of the hepatitis B surface antigen vaccine--I. Treatment of immobilized HBsAg by dissociation agents with or without enzymatic digestion and identification of polypeptides by protein blotting.
    Pillot J; Petit MA
    Mol Immunol; 1984 Jan; 21(1):53-60. PubMed ID: 6423972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of solvent environment on the structure of hepatitis B surface antigen (HBsAg)].
    Yuan H; Li Y; Huang Y; Luo J; Ma G; Su Z
    Sheng Wu Gong Cheng Xue Bao; 2010 Dec; 26(12):1674-82. PubMed ID: 21387830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of serum proteins and potential virus contaminants during hepatitis B vaccine preparation.
    Adamowicz P; Chabanier G; Hyafil F; Lucas G; Prunet P; Reculard P; Vinas R
    Vaccine; 1984 Sep; 2(3):209-14. PubMed ID: 6241769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the recovery of clarification process of recombinant hepatitis B surface antigen in large-scale by optimizing adsorption-desorption parameters on Aerosil-380.
    Hosseini SN; Ghaisari P; Sharifnia S; Khatami M; Javidanbardan A
    Prep Biochem Biotechnol; 2018; 48(6):490-497. PubMed ID: 29932813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing.
    Zahid M; Lünsdorf H; Rinas U
    Vaccine; 2015 Jul; 33(31):3739-45. PubMed ID: 26079614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris.
    Hardy E; Martínez E; Diago D; Díaz R; González D; Herrera L
    J Biotechnol; 2000 Feb; 77(2-3):157-67. PubMed ID: 10682276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.